Cellular

Gene test predicts sudden cardiac death

Identification of rare DNA variants might flag up individuals at high risk of cardiac death before any symptoms appear. Globally, sudden and unexpected cardiac death...

Could cytotoxic T cells be a key to Longevity?

Scientists have used single-cell RNA analysis to find that supercentenarians - meaning people over the age of 110 - have an excess of an...

Out of stealth and probing the dark side of DNA

Ervaxx CEO looks to raise new funding in 2020 to continue momentum on top of $17.5m Series A. Earlier this month, we reported on UK...

Vertex/CRISPR therapy: Longevity landmark?

Could an exciting breakthrough in the treatment of blood disorders by gene editing hold the key to improving Longevity and delaying senescence? The first two...

Latest articles

CMS to invest £25m in UK start-ups

A collaboration between AstraZeneca, Cambridge Judge and Chinese pharmaceutical company CMS aims to close the funding gap for biotech and life sciences start-ups in...

AgeX and Lineage granted pluripotent patent

AgeX Therapeutics and Lineage Cell Therapeutics awarded US patent for 'Method of Generating Induced Pluripotent Stem Cells'. AgeX Therapeutics, Inc. and Lineage Cell Therapeutics, Inc. today announced...

Artificial neurons created on microchip

A major breakthrough for neural technology as scientists reproduce the electrical properties of neurons on a semiconductor chip. Researchers at Bath have made a world...

Longevity stocks: Go public with caution

SENS chief warns Longevity companies on perils of floating too soon. There is no doubt that the Longevity market is starting to take off. But...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.